Table 3:
Descriptive statistics of orbital lesion ADC across the largest source datasets (ADC in units of 10−3 mm2/s)
| All Lesions (n = 183) | Sepahdari et al13 (n = 50) | Politi et al17 (n = 90) | Razek et al16 (n = 43) | |
|---|---|---|---|---|
| Benign lesion ADC (mean, 95% CI) | 1.42 ± 0.41 (1.34–1.51) | 1.36 ± 0.41 (1.22–1.51) | 1.39 ± 0.42 (1.25–1.54) | 1.53 ± 0.35 (1.37–1.67) |
| Malignant lesion ADC (mean, 95% CI) | 0.90 ± 0.37 (0.83–0.98) | 1.02 ± 0.42 (0.80–1.24) | 0.88 ± 0.36 (0.79–0.98) | 0.80 ± 0.34 (0.65–0.95) |
| Lymphoma ADC (mean, 95% CI) | 0.67 ± 0.09 (0.64–0.69) | 0.69 ± 0.16 (0.58–0.86)a | 0.67 ± 0.07 (0.60–0.75) | 0.67 ± 0.07 (0.60–0.73)a |
| Inflammatory lesion ADC (mean, 95% CI) | 1.40 ± 0.31 (1.30–1.50) | 1.42 ± 0.37 (1.24–1.60) | 1.45 ± 0.26 (1.29–1.60) | 1.24 ± 0.13 (1.18–1.33)a |
| Area under ROC curve (95% CI) | 0.84 (0.79–0.90) | 0.74 (0.58–0.89) | 0.86 (0.79–0.94) | 0.95 (0.87–1.0) |
a
The 25th-75th percentile range was reported due to a sample size too small to assume normal distribution.